Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

$27.3 Billion Antithrombotic/Anticoagulant Drugs Market - Technologies and Global Analysis to 2021 - Research and Markets

Research and Markets
Posted on: 19 Sep 16

Research and Markets has announced the addition of the "Antithrombotic/Anticoagulant Drugs - Technologies and Global Markets" report to their offering.

This report is a comprehensive business tool designed to provide an in-depth look at antithrombotic/anticoagulant drugs for various cardiovascular applications. The geographic scope of the report is global, with a special emphasis on individual regions such as the United States, Europe, Asia-Pacific and the rest of world. The report describes the industry, its relationship to the healthcare industry and its participants and future trends.

This report provides:

  • An overview of the global market for antithrombotic/anticoagulant drugs, which is changing due to factors such as an aging population, an increase in thrombotic events, and recent advances in pharmaceuticals
  • Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021
  • Breakdowns of the market size of anticoagulants by revenue at manufacturers' sales levels, including low molecular weight heparins and oral anticoagulants, as well as breakdowns of antiplatelets and thrombin inhibitors
  • Discussion of research and development of antithrombotic/anticoagulant treatments
  • Profiles of top leaders in each of the market segments along with companies that are novel or have specific interest to the field

Categories discussed in the report include:

  • Anticoagulants.
  • Antiplatelets.
  • Thrombin inhibitors.

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Industry Overview

4: Anticoagulants

5: Antiplatelets

6: Thrombin Inhibitors

7: Company Profiles

8: Appendix A: List Of Patents

9: Appendix B: Directory Of Companies Covered In This Report

Companies Mentioned

  • Abbott Laboratories
  • Armetheon Inc.
  • Astrazeneca
  • Baxter International
  • Bayer AG
  • Biovascular Inc.
  • Boehringer Ingelheim Gmbh
  • Bristol-Myers Squibb Co.
  • CSL Behring
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly
  • Emisphere Technologies
  • F. Hoffmann-La Roche AG
  • Genentech
  • Glaxosmithkline
  • Johnson & Johnson
  • Ligand Pharmaceuticals Inc.
  • The Medicines Co.
  • Merck
  • Merrion Pharmaceuticals Ltd.
  • Microbix Biosystems Inc.
  • Novartis
  • ONO Pharmaceutical Co. Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Portola Pharmaceuticals
  • Revo Biologics Inc.
  • Sanofi
  • Santa Cruz Biotechnology Inc.
  • Servier Laboratories
  • Shire Pharmaceuticals
  • Sun Pharmaceuticals
  • TEVA Pharmaceuticals Ltd.

For more information about this report visit http://www.researchandmarkets.com/research/ctkh8d/antithromboticant

Related Topics: Hematological Drugs

View source version on businesswire.com: http://www.businesswire.com/news/home/20160919005512/en/

Business Wire
www.businesswire.com

Last updated on: 19/09/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.